Dr. Syrine Ben Dhaou received the Second Place Poster award in the Postdoctoral Fellow category at the Feist Cardiovascular Research Symposium for her poster entitled: “Targeting endothelial Nck1 reduces atherosclerosis”.

Brenna Pearson-Gallion received the Second Place Poster in the Graduate Student category at the Feist Cardiovascular Research Symposium for her poster entitled: Altered EphA2 signaling in Nonalcoholic Fatty Liver Disease Progression”.

318Forum - LSUHS researchers, Dr. Oren Rom and Dr. Alexandra Finney, share why there has been a steady rise in heart disease - related deaths since the early 1900s and what current research studies are learning.

Dr. Oren S. Rom gave an oral presentation at the Keystone Symposia meeting held in Whistler, British Columbia, Canada, August 7 – August 11, 2022.

Dr. Alexandra Finney was recently awarded the CCDS Malcolm Feist Postdoctoral Fellowship grant entitled: Macrophage serine hydroxymethyltransferase-2 modulates mitochondrial function and lipid metabolism in atherosclerosis.

Dr. Oren S. Rom was awarded the Research Rising Star Award at the 4th Annual Research Celebration at LSU Health Shreveport.

Dr. Oren S. Rom was recently awarded a 5-year NIH/NIDDK R01 grant entitled: Lipidated Amino Acids in Cardiometabolic Diseases.

Dr. Nirav Dhanesha was recently awarded a 5-year NIH/NHLBI R01 grant entitled: Mechanisms for Deep Vein Thrombosis following Stroke.

Dr. Alexandra Finney received first place at the Biomedical Research and Industry Day (BRAID) for her poster entitled: Loss of serine hydroxymethyltransferase 2 in macrophages enhances atherosclerosis plaque size while reducing macrophage mitochondrial respiration.

Dr. Oren S. Rom gave an oral presentation at the European Hyperoxaluria Consortium, OxalEurope, held in Berlin, Germany, September 28 – October 2, 2022.

The Rom Lab’s study titled “Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis” was published in Redox Biology, June, 2022. 

This prestigious award, sponsored by the American Heart Association’s Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB Council), recognizes investigators in the formative years of their faculty careers who have the potential to become future leaders in cardiovascular research.